487 related articles for article (PubMed ID: 16843838)
1. 99mTc-labeled annexin V fragments: a potential SPECT radiopharmaceutical for imaging cell death.
Mukherjee A; Kothari K; Tóth G; Szemenyei E; Sarma HD; Környei J; Venkatesh M
Nucl Med Biol; 2006 Jul; 33(5):635-43. PubMed ID: 16843838
[TBL] [Abstract][Full Text] [Related]
2. Structural requirements for in vivo detection of cell death with 99mTc-annexin V.
Tait JF; Smith C; Blankenberg FG
J Nucl Med; 2005 May; 46(5):807-15. PubMed ID: 15872355
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of a (99m)Tc-MAMA-propyl-thymidine complex as a potential probe for in vivo visualization of tumor cell proliferation with SPECT.
Celen S; de Groot T; Balzarini J; Vunckx K; Terwinghe C; Vermaelen P; Van Berckelaer L; Vanbilloen H; Nuyts J; Mortelmans L; Verbruggen A; Bormans G
Nucl Med Biol; 2007 Apr; 34(3):283-91. PubMed ID: 17383578
[TBL] [Abstract][Full Text] [Related]
4. Detection of apoptotic tumor response in vivo after a single dose of chemotherapy with 99mTc-annexin V.
Mochizuki T; Kuge Y; Zhao S; Tsukamoto E; Hosokawa M; Strauss HW; Blankenberg FG; Tait JF; Tamaki N
J Nucl Med; 2003 Jan; 44(1):92-7. PubMed ID: 12515881
[TBL] [Abstract][Full Text] [Related]
5. A simplified method for preparation of 99mTc-annexin V and its biologic evaluation for in vivo imaging of apoptosis after photodynamic therapy.
Subbarayan M; Häfeli UO; Feyes DK; Unnithan J; Emancipator SN; Mukhtar H
J Nucl Med; 2003 Apr; 44(4):650-6. PubMed ID: 12679412
[TBL] [Abstract][Full Text] [Related]
6. Optimization of the preparation of 99mTc-labeled Hynic-derivatized Annexin V for human use.
Verbeke K; Kieffer D; Vanderheyden JL; Reutelingsperger C; Steinmetz N; Green A; Verbruggen A
Nucl Med Biol; 2003 Oct; 30(7):771-8. PubMed ID: 14499336
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of adenosine preconditioning with 99mTc-His10-annexin V in a porcine model of myocardium ischemia and reperfusion injury: preliminary study.
Ye F; Fang W; Wang F; Hua ZC; Wang Z; Yang X
Nucl Med Biol; 2011 May; 38(4):567-74. PubMed ID: 21531294
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evaluation of [99mTc]-labeled tricarbonyl His-annexin A5 as an imaging agent for the detection of phosphatidylserine-expressing cells.
Vangestel C; Peeters M; Oltenfreiter R; D'Asseler Y; Staelens S; Van Steenkiste M; Philippé J; Kusters D; Reutelingsperger C; Van Damme N; Van de Wiele C
Nucl Med Biol; 2010 Nov; 37(8):965-75. PubMed ID: 21055628
[TBL] [Abstract][Full Text] [Related]
9. Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis.
Ohtsuki K; Akashi K; Aoka Y; Blankenberg FG; Kopiwoda S; Tait JF; Strauss HW
Eur J Nucl Med; 1999 Oct; 26(10):1251-8. PubMed ID: 10541822
[TBL] [Abstract][Full Text] [Related]
10. Preliminary biological evaluation of novel (99m)Tc-Cys-annexin A5 as a apoptosis imaging agent.
Lu C; Jiang Q; Hu M; Tan C; Ji Y; Yu H; Hua Z
Molecules; 2013 Jun; 18(6):6908-18. PubMed ID: 23752473
[TBL] [Abstract][Full Text] [Related]
11. In vivo imaging of radiation-induced tissue apoptosis by (99m)Tc(I)-his (6)-annexin A5.
Lin KJ; Wu CC; Pan YH; Chen FH; Fu SY; Chiang CS; Hong JH; Lo JM
Ann Nucl Med; 2012 Apr; 26(3):272-80. PubMed ID: 22278351
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of Tc-99m-labeled RRL-containing peptide as a non-invasive tumor imaging agent in a mouse fibrosarcoma model.
Kim DW; Kim WH; Kim MH; Kim CG
Ann Nucl Med; 2015 Nov; 29(9):779-85. PubMed ID: 26179963
[TBL] [Abstract][Full Text] [Related]
13. Enhanced apoptotic reaction correlates with suppressed tumor glucose utilization after cytotoxic chemotherapy: use of 99mTc-Annexin V, 18F-FDG, and histologic evaluation.
Takei T; Kuge Y; Zhao S; Sato M; Strauss HW; Blankenberg FG; Tait JF; Tamaki N
J Nucl Med; 2005 May; 46(5):794-9. PubMed ID: 15872353
[TBL] [Abstract][Full Text] [Related]
14. Preparation, in vitro and in vivo evaluation of (99m)Tc-Annexin B1: a novel radioligand for apoptosis imaging.
Luo QY; Zhang ZY; Wang F; Lu HK; Guo YZ; Zhu RS
Biochem Biophys Res Commun; 2005 Oct; 335(4):1102-6. PubMed ID: 16105648
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of 99mTc(CO)3-BPy-RGD complex as alphav beta3 integrin receptor-targeted imaging agent.
Zhang X; Chen X
Appl Radiat Isot; 2007 Jan; 65(1):70-8. PubMed ID: 17011200
[TBL] [Abstract][Full Text] [Related]
16. 99mTc-Hynic-annexin V imaging to evaluate inflammation and apoptosis in rats with autoimmune myocarditis.
Tokita N; Hasegawa S; Maruyama K; Izumi T; Blankenberg FG; Tait JF; Strauss HW; Nishimura T
Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):232-8. PubMed ID: 12552341
[TBL] [Abstract][Full Text] [Related]
17. Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies.
Faintuch BL; Teodoro R; Duatti A; Muramoto E; Faintuch S; Smith CJ
Nucl Med Biol; 2008 May; 35(4):401-11. PubMed ID: 18482677
[TBL] [Abstract][Full Text] [Related]
18. Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine.
Ahlgren S; Wållberg H; Tran TA; Widström C; Hjertman M; Abrahmsén L; Berndorff D; Dinkelborg LM; Cyr JE; Feldwisch J; Orlova A; Tolmachev V
J Nucl Med; 2009 May; 50(5):781-9. PubMed ID: 19372467
[TBL] [Abstract][Full Text] [Related]
19. Time course of Paclitaxel-induced apoptosis in an experimental model of virus-induced breast cancer.
Erba PA; Manfredi C; Lazzeri E; Minichilli F; Pauwels EK; Sbrana A; Strauss HW; Mariani G
J Nucl Med; 2010 May; 51(5):775-81. PubMed ID: 20395330
[TBL] [Abstract][Full Text] [Related]
20. Favorable biokinetic and tumor-targeting properties of 99mTc-labeled glucosamino RGD and effect of paclitaxel therapy.
Jung KH; Lee KH; Paik JY; Ko BH; Bae JS; Lee BC; Sung HJ; Kim DH; Choe YS; Chi DY
J Nucl Med; 2006 Dec; 47(12):2000-7. PubMed ID: 17138743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
